EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes

Namit Chaudhary, Alexandra N Newby iD, Mariah L Arral iD, Saigopalakrishna S Yerneni iD, Samuel T LoPresti, Rose Doerfler, Daria M Strelkova Petersen iD, Catalina Montoya iD, Julie S Kim iD, Bethany Fox, Tiffany Coon, Angela Malaney iD und 2 weitere

Proceedings of the National Academy of Sciences · 12.03.2024 · 121 (11)

DOI: 10.1073/pnas.2307810121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.03.2024. Verfasst von Namit Chaudhary und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213. Hauptthemen laut MEDLINE: Endothelial Cells, Fetus, Liposomes, Nanoparticles. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, HHS | NIH | Office of Extramural Research, National Institutes of Health, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treating pregnancy-related disorders is exceptionally challenging because the threat of maternal and/or fetal toxicity discourages the use of existing medications and hinders new drug development. One potential solution is the use of lipid nanoparticle (LNP) RNA therapies, given their proven efficacy, tolerability, and lack of fetal accumulation. Here, we describe LNPs for efficacious mRNA delivery to maternal organs in pregnant mice via several routes of administration. In the placenta, our lead LNP transfected trophoblasts, endothelial cells, and immune cells, with efficacy being structurally dependent on the ionizable lipid polyamine headgroup. Next, we show that LNP-induced maternal inflammatory responses affect mRNA expression in the maternal compartment and hinder neonatal development. Specifically, pro-inflammatory LNP structures and routes of administration curtailed efficacy in maternal lymphoid organs in an IL-1β-dependent manner. Further, immunogenic LNPs provoked the infiltration of adaptive immune cells into the placenta and restricted pup growth after birth. Together, our results provide mechanism-based structural guidance on the design of potent LNPs for safe use during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsFetusLiposomesNanoparticlesFemalePregnancyHumansAnimalsMiceRNA, MessengerPrenatal Care

Stichwörter der Autor:innen

LNPsfetal toxicitylipid nanoparticlesmRNA deliverymaternal health

Substanzen

Lipid NanoparticlesRNA, MessengerLiposomes

Autor:innen und Institutionen

  • Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213.
  • Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213.
  • Mellon Institute Centralized Vivarium, Carnegie Mellon University, Pittsburgh, PA 15213.
  • Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213.

ORCID-Profile: Alexandra N Newby, Mariah L Arral, Saigopalakrishna S Yerneni, Daria M Strelkova Petersen, Catalina Montoya, Julie S Kim, Angela Malaney, Yoel Sadovsky, Kathryn A Whitehead

Förderung

  • NICHD NIH HHS
  • HHS | NIH | Office of Extramural Research, National Institutes of Health
  • National Science Foundation

Zitieren

APA

Chaudhary, N., Newby, A. N., Arral, M. L., Yerneni, S. S., LoPresti, S. T., Doerfler, R., Petersen, D. M. S., Montoya, C., Kim, J. S., Fox, B., Coon, T., Malaney, A., Sadovsky, Y., & Whitehead, K. A. (2024). Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. Proceedings of the National Academy of Sciences, 121(11). https://doi.org/10.1073/pnas.2307810121

Vancouver

Chaudhary N, Newby AN, Arral ML, Yerneni SS, LoPresti ST, Doerfler R, et al. Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes. Proceedings of the National Academy of Sciences. 2024;121(11). doi:10.1073/pnas.2307810121

BibTeX
@article{Chaudhary2024,
  author = {Chaudhary, Namit and Newby, Alexandra N and Arral, Mariah L and Yerneni, Saigopalakrishna S and LoPresti, Samuel T and Doerfler, Rose and Petersen, Daria M Strelkova and Montoya, Catalina and Kim, Julie S and Fox, Bethany and Coon, Tiffany and Malaney, Angela and Sadovsky, Yoel and Whitehead, Kathryn A},
  title = {Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {11},
  doi = {10.1073/pnas.2307810121}
}
Kostenlos starten →